fda glp-1 compounding crackdown news october 2025 Despite crackdown, unapproved GLP-1s still threaten the industry FDA cracks down on 'misleading'
Description
The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its other GLP-1 products.
Trulicity offers a simple, once-weekly way to control type 2 diabetes and prevent cardiovascular disease (CVD) or help with existing CVD
Foundayo launches on April 6 at the same price as Novo's pill, threatening to reshape the $50 billion obesity drug market before Novo's first-quarter...
brands to sell their products to millions of customers in the Indo-Pacific through Coupangs AI-powered fulfillment and logistics network
About 1 in 8 Americans have used GLP-1 drugs
